Reproduction
(2005)
129
403-409
DOI: 10.1530/rep.1.0542
Copyright © 2005 Society for Reproduction and Fertility
Inducible nitric oxide synthase-derived nitric oxide regulates germinal vesicle breakdown and first polar body emission in the mouse oocyte
Li-Jun Huo1,2,
Cheng-Guang Liang1,2,
Ling-Zhu Yu1,2,
Zhi-Sheng Zhong1,2,
Zeng-Ming Yang3,
Heng-Yu Fan4,
Da-Yuan Chen1 and
Qing-Yuan Sun1
1 State Key Laboratory of Reproductive Biology, Institute of Zoology and 2 Graduate School, Chinese Academy of Sciences, Beijing 100080, China, 3 College of Life Science, Northeast Agricultural University, Harbin 150030, China and 4 Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Correspondence should be addressed to Q-Y Sun; Email: sunqy1{at}yahoo.com
 |
Abstract
|
|---|
The present study investigated the subcellular localization of inducible nitric oxide synthase (iNOS) during mouse oocyte meiotic maturation and fertilization using confocal microscopy, and further studied the roles of iNOS-derived NO in oocyte maturation by using an iNOS-specific inhibitor aminoguanidine (AG) and iNOS antibody microinjection. In germinal vesicle-stage oocytes, iNOS immunoreactivity was mainly localized in the germinal vesicle. Shortly after germinal vesicle breakdown, the iNOS immunoreactivity accumulated around the condensed chromosomes. At metaphase I and metaphase II, with the organization of chromosomes to the equatorial plate, iNOS immunoreactivity was concentrated around the aligned chromosomes, putatively the position of the metaphase spindle. The accumulation of iNOS immunoreactivity could not be detected at anaphase I and anaphase II. However, at telophase I and telophase II, the staining of iNOS was concentrated in the region between the separating chromosomes/chromatids. Furthermore, the staining of iNOS also accumulated in the male and female pronuclei in fertilized eggs. Germinal vesicle breakdown and the first polar body emission of the oocytes were significantly blocked by the iNOS-specific inhibitor AG in a dose-dependent manner. The germinal vesicle breakdown in oocytes injected with iNOS antibody was also inhibited. We found that the phosphorylation of mitogen-activated protein kinase in oocytes after germinal vesicle breakdown was inhibited by AG treatment. The control oocytes extruded a normal first polar body, while the AG-treated oocytes exhibited an elongated protrusion or no elongated protrusion. The results of confocal microscopy showed that the AG-treated oocytes were arrested at anaphase Itelophase I. Our results suggest that the iNOS-derived NO pathway plays important roles in mouse oocyte meiotic maturation, especially in germinal vesicle breakdown and the anaphasetelophase transition.
 |
Introduction
|
|---|
Fully-grown mammalian oocytes are arrested at the diplotene stage of the first meiotic prophase, which is also termed the germinal vesicle (GV) stage. GV-stage-arrested oocytes can spontaneously resume meiosis when they are released from the inhibitory environment of follicles. However, these oocytes arrest again at the metaphase of meiosis II. With the separation of sister chromatids and emission of the second polar body triggered by fertilization, meiosis is completed (Josefsberg et al. 2001). Nitric oxide (NO), a cell messenger, is formed from L-arginine by isoforms of NO synthases (NOSs) via NG-hydroxy-L-arginine, with L-citrulline as a by-product. Isoforms of NOSs are composed of neuronal NOS, endothelial NOS (eNOS) and inducible NOS (iNOS). NO plays multiple roles in different biological systems, and it is implicated in the control of follicle and oocyte function (Mitchell et al. 2004). It has been reported that iNOS or eNOS could be detected in porcine or mouse follicles, granulosa cells, cumulus cells and oocytes (Hattori et al. 2001, Takesue et al. 2003, Mitchell et al. 2004). Expression of eNOS increases after the luteinizing hormone surge or human chorionic gonadotropin (hCG) injection (Van Voorhis et al. 1995, Jablonka-Shariff & Olson 1998, Nakamura et al. 1999), and eNOS-derived NO stimulates the ovulatory process (Shukovski & Tsafriri 1994, Powers et al. 1995, Bonello et al. 1996, Hesla et al. 1997, Yamauchi et al. 1997, Jablonka-Shariff & Olson 1998, Jablonka-Shariff et al. 1999). The reports about changes in iNOS expression during this process are controversial (Matsumi et al. 1998), and the role of iNOS-derived NO is unclear. NOS inhibitors, N-omega-nitro-L-arginine methyl ester (L-NAME), N-omega-nitro-L-arginine (L-NNA) or amino-guanidine (AG) bicarbonate salt affected the process of oocyte meiotic maturation, including inhibition of GV breakdown (GVBD) and the first polar body (PB1) emission in in vitro cultured pig, mouse or rat oocytes (Blashkiv et al. 2001, Bu et al. 2003, Voznesenska & Blashkiv 2003, Tao et al. 2004). The results from experiments using NO donors also suggest that NO may have crucial roles in oocyte maturation, such as GVBD (Sengoku et al. 2001, Voznesenska & Blashkiv 2003). On the other hand, others reported that AG promotes GVBD in mouse preovulatory follicles, and S-nitroso-L-acetyl penicillamine (SNAP), an NO donor, prevented this effect; SNAP dose-dependently inhibited GVBD in denuded oocytes (DOs) (Nakamura et al. 2002). But it has also been found that NO has dual functions (stimulation or inhibition) in mouse meiotic maturation depending on its concentration (Bu et al. 2003). Overall, the exact roles of NO in oocyte maturation remain unclear and need to be further studied. In this study, we for the first time revealed the subcellular localization of iNOS at different stages of mouse oocyte meiotic maturation and fertilization by confocal microscopy. Since the reports on the role of NO in GVBD are still controversial and since it is still not clear at what stage the NO acts to affect the meiotic cell cycle after GVBD, we further investigated the roles of iNOS-derived NO in mouse oocyte maturation by using the iNOS-specific inhibitor, AG, and iNOS antibody microinjection. Our findings show that iNOS-derived NO is required for GVBD and anaphasetelophase transition.
 |
Materials and Methods
|
|---|
Chemicals and solutions
Polyclonal rabbit anti-murine iNOS antibody and the iNOS-specific inhibitor AG were purchased from Cayman Chemical Company (Ann Arbor MI, USA). AG was diluted just before use. All other chemicals or components of media were embryo culture or cell culture grade and were obtained from Sigma unless otherwise noted.
Mouse oocyte and zygote collection
Kunming mice, a native breed widely used in biological research in China, were used for oocyte and zygote collection. Animal care and handling were conducted in accordance with policies promulgated by the ethical committee of the Institute of Zoology, Chinese Academy of Sciences. Both denuded and cumulus-enclosed GV-intact oocytes were obtained as previously described by Tong et al.(2002) and maintained in M2 medium supplemented with 60 µg/ml penicillin and 50 µg/ml streptomycin, and cultured in M2 medium. All cultures were carried out at 37°C in a humidified atmosphere of 5% CO2. The oocytes at different stages were collected for confocal microscopy. For the collection of metaphase II-arrested eggs, females were superovulated by i.p. injection of 10 IU pregnant mare serum gonadotropin followed 4648 h later with 10 IU hCG. Mice were killed and oviducts were removed at 1416 h after hCG injection. Using a pair of fine forceps to tear the oviducts, cumulus masses were collected in M2 medium. To remove the cumulus cells, eggs were briefly exposed to 300 IU/ml hyaluronidase followed by three washes in M2 medium. In vitro fertilization was performed using 1 x 106/ml motile cauda epididymal sperm, which had been previously capacitated in M16 medium with 2.5 mM taurine for 1 h. The fertilized eggs were collected at different stages for confocal microscopy.
Confocal microscopy of mouse oocytes
After removal of Zona Pellucida in acidified Tyrodes solution (pH 2.5), oocytes or embryos at the desired stages were fixed in 4% paraformaldehyde in PBS for 30 min, permeabilized for 30 min in the incubation buffer (0.5% Triton X-100 in 20 mM Hepes, pH 7.4, 3 mM MgCl2, 50 mM NaCl, 300 mM sucrose, 0.02% NaN3), then washed in PBS with 0.1% Tween 20 three times, and finally incubated with polyclonal rabbit anti-human iNOS antibody diluted 1:100 for 1 h. The oocytes or fertilized eggs were rinsed three times and incubated for 1 h with 1:100 FITC-conjugated goat anti-rabbit IgG, followed by three washes and staining with 10 µg/ml propidium iodide. Finally, the oocytes or fertilized eggs were added to a glass slide, mounted in 1,4-diazabicyclo(2.2.2)octane hydrochloride-containing medium, and covered with a coverglass. The samples were examined using a TCS-4D laser scanning confocal microscope (Leica Microsystems, Bensheim, Germany). As a negative control, the first antibody was replaced by rabbit IgG.
Antibody microinjection
Polyclonal rabbit anti-human iNOS antibody (100 µg/ml in PBS) was injected into the GV-arrested oocytes as described by Tong et al.(2002). An Eppendoff microinjector was used in this experiment. All microinjections were performed by using a beveled micropipette to minimize damage and were finished within 30 min. A microinjection volume of about 7 pl per oocyte was used in all experiments. Each experiment consisted of three separate groups and approximately 50 oocytes were injected in each group. The same amount of rabbit IgG was injected into the oocytes as the negative control. 3-Isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, was always included at 4 mM in M2 medium to prevent oocyte GVBD during the process of antibody microinjection. After microinjection of iNOS antibody, the oocytes were thoroughly washed in M2 medium and then cultured for 2 h, and then the GVBD was examined.
Western blot analysis
For detection of active ERK1/2, proteins from 50 oocytes were collected in SDS sample buffer and heated to 100 °C for 4 min. After cooling on ice and centrifuging at 12 000 g for 3 min, samples were frozen at 20 °C until use. The total proteins were separated by SDS-PAGE with a 4% stacking gel and a 10% separating gel for 30 min at 90 V and 2.5 h at 120 V respectively, and then electrophoretically transferred onto nitrocellulose membrane for 2.5 h at 200 mA, at 4 °C. Then the membrane was blocked overnight at 4 °C in TBST buffer (20 mM Tris, 137 mM NaCl, 0.1% Tween 20, pH 7.4) containing 5% low-fat milk. After that, the membrane was incubated for 2 h at 37 °C in TBST with 1:500 mouse anti-human p-ERK1/2 antibody. After three washes of 10 min each in TBST, the membrane was incubated for 1 h at 37 °C with horseradish peroxidase-conjugated rabbit anti-mouse IgG diluted 1:1000 in TBST. The membranes were washed three times in TBST and then processed using an enhanced chemiluminescence detection system (Amersham). All experiments were repeated at least three times.
Statistical analysis
All percentages from three repeated experiments are expressed as means±S.E.M. and the numbers of oocytes observed are labeled in brackets as (n = ). All frequencies were subjected to arcsin transformation. The transformed data were statistically compared by ANOVA using SPSS software followed by StudentNewmanKeuls test. Differences at P < 0.05 were considered to be statistically significant.
Experimental design
Experiment 1
The subcellular localization of iNOS during normal oocyte meiotic maturation and fertilization was examined by confocal microscopy.
Experiment 2
To study the role of iNOS-derived NO during oocyte GVBD, fully grown GV-intact oocytes were collected and cultured in M2 medium containing 0, 1, 10 or 50 mM iNOS-specific inhibitor AG for 14 h. At the end of culture, the oocytes were examined for GV integrity or collected for Western blotting. Furthermore, the GV-stage-arrested oocytes were microinjected with iNOS antibody and then cultured for 2 h, and the GVBD was examined at the end of the culture.
Experiment 3
To study the possible roles of iNOS-derived NO during the PB1 emission, fully grown GV-intact oocytes were collected and cultured in M2 medium for 4 h and then the oocytes that had undergone GVBD were collected and cultured in M2 medium containing 0, 1 or 10 mM AG for an additional 12 h. At the end of culture, the oocytes were examined for PB1 emission or collected for confocal microscopy.
 |
Results
|
|---|
Subcellular localization of iNOS during oocytes meiotic maturation and fertilization
The subcellular localization of iNOS during mouse oocyte meiotic maturation and fertilization is shown in Fig. 1
. The specimens were stained with propidium iodide to visualize the DNA and confirm the stage of meiotic maturation. The localization of iNOS varied at different developmental stages. In GV-stage oocytes, iNOS immunoreactivity was mainly localized in the GV (Fig. 1A
). Shortly after GVBD, iNOS immunoreactivity accumulated around the condensed chromosomes (Fig. 1B
). At metaphase I (Fig. 1C
) and metaphase II (Fig. 1F
), with the organization of chromosomes to the equatorial plate, the immunoreactivity of iNOS was concentrated around the aligned chromosomes, putatively the position of the metaphase spindle. The accumulation of iNOS immunoreactivity in the spindle region could not be detected at anaphase I (Fig. 1D
) and anaphase II (Fig. 1G
); however, at telophase I (Fig. 3E
) and telophase II (Fig. 1H
), the staining of iNOS was concentrated in the region between the separating chromosomes. Furthermore, the staining of iNOS also accumulated in the male and female pronuclei in fertilized eggs (Fig. 1I
).

View larger version (118K):
[in this window]
[in a new window]
|
Figure 1 The distribution of iNOS during mouse oocyte meiotic maturation and fertilization. Red, DNA; green, iNOS. iNOS was mainly localized in the GV (A). Shortly after GVBD, iNOS accumulated around the condensed chromosomes (B). At metaphase I (C) and metaphase II (F), iNOS was concentrated around the aligned chromosomes, putatively the position of the metaphase spindle. The accumulation of iNOS could not be detected at anaphase I (D) and anaphase II (G); however, at telophase I (E) and telophase II (H), the staining of iNOS was concentrated in the region between the separating chromosomes/chromatids. iNOS accumulated in the male and female pronuclei in fertilized eggs (I).
|
|

View larger version (38K):
[in this window]
[in a new window]
|
Figure 3 iNOS-specific inhibitor blocks PB1 emission. GV-arrested oocytes were cultured in M2 medium with different concentrations of AG for 12 h. At the end of culture, the oocytes were examined for PB1 emission (A) or collected for confocal microscopy (B). The PB1 emission of oocytes was blocked by the iNOS-specific inhibitor AG in a dose-dependent manner (A). Means±S.E.M. Letters a, b, c above columns denote significant differences at P < 0.05. The AG-treated oocytes were arrested at anaphase Itelophase I transition (Bb and Bc). The control oocytes were arrested at metaphase II (Ba).
|
|
Inhibition of iNOS-derived NO prevents oocyte GVBD
As shown in Fig. 2A
, the GVBD of the DOs was significantly blocked by iNOS-specific inhibitor AG in a dose-dependent manner. The GVBD rate of cumulus-enclosed oocytes (CEOs) was 94% (n = 160), while the GVBD of CEOs was completely inhibited by 50 mM AG (n = 112). Furthermore, the phosphorylation of mitogen-activated protein kinase (MAPK) in the control oocytes could be detected at 14 h after culture in M2 medium, but was completely inhibited in 50 mM AG-treated oocytes (Fig. 2B
). We also found that the GVBD of oocytes microinjected with iNOS antibody was evidently inhibited (33%, n = 106) compared with the control group (66%, n = 120).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 2 Inhibition of iNOS-derived NO prevents oocyte GVBD and MAPK phosphorylation. GVBD was observed 14 h after culture. The GVBD of the DOs was significantly inhibited by the iNOS-specific inhibitor AG in a dose-dependent manner (A). Means ± S.E.M. Letters a, b, c, d above columns denote significant differences at P < 0.05. Phosphorylation of MAPK in control oocytes was significantly higher than that in AG-treated oocytes (B).
|
|
iNOS-specific inhibitor blocks PB1 emission
As shown in Fig. 3A
, the PB1 emission of oocytes was blocked by the iNOS-specific inhibitor AG in a dose-dependent manner. The PB1 emission rate of DOs was 78 ± 5% in the control group, but was only 37 ± 4% in 1 mM AG-treated oocytes, and PB1 emission was completely inhibited by 10 mM AG. The AG-treated oocytes exhibited an elongated protrusion or no elongated protrusion. The results of
-tubulin staining examined by confocal microscopy showed that the control oocytes were arrested at the metaphase II and a normal PB1 was extruded (Fig. 3Ba
), while the AG-treated oocytes were arrested at anaphase Itelophase I transition (Fig. 3Bc and b
).
 |
Discussion
|
|---|
NO plays multiple roles in different biological systems, and it is implicated in the control of ovary and follicle function, such as follicle development, ovulation and ovarian steroidogenesis (Jablonka-Shariff et al. 1999, Mitchell et al. 2004). Although numerous experiments have revealed that the NO pathway affects ovarian function and follicle development (Hattori et al. 2001, Takesue et al. 2003, Mitchell et al. 2004), most results are derived from the follicles or the interaction between the oocyte and granulosa cells, while whether NO acts directly on oocytes, especially what function iNOS-derived NO plays during oocyte meiosis, is unclear (Bu et al. 2003, Tao et al. 2004). In this study, we for the first time revealed the subcellular localization of iNOS at different stages of mouse oocyte meiotic maturation and fertilization using confocal microscopy, and by using the iNOS-specific inhibitor AG and antibody microinjection, we studied the roles and the possible mechanisms of iNOS-derived NO in GVBD and PB1 emission. Our results show that iNOS has a specific subcellular localization throughout oocyte maturation. The process of GVBD and the PB1 emission of oocytes was significantly inhibited by iNOS-specific inhibitor AG in a dose-dependent manner. The phosphorylation of MAPK was inhibited by AG and the PB1 emission process was arrested at the anaphasetelophase transition. Our results also show that the GVBD of oocytes injected with iNOS antibody was inhibited compared with the control group. Our results suggest that the iNOS-derived NO pathway plays a crucial role in mouse oocyte meiotic maturation, especially in GVBD and the anaphasetelophase transition. It has been shown that eNOS is expressed in the porcine oocyte, granulosa cells and cumulus cells (Hattori et al. 2001, Takesue et al. 2003). iNOS and eNOS were localized in mouse ovaries, and omission of L-arginine significantly reduced follicle survival and ovulation (Nishikimi et al. 2001, Nemade et al. 2002, Mitchell et al. 2004, Tao et al. 2004). Furthermore, by using an NO donor and NO inhibitor, it has been proven that the NO pathway plays important roles in ovarian function and follicle development (Sengoku et al. 2001). The ovarian defects observed in eNOS knock-out mice suggest that eNOS-derived NO is a modulator of oocyte meiotic maturation (Jablonka-Shariff & Olson 2000). Our results showed that iNOS concentrated in the GV. The phosphorylation of MAPK was inhibited by AG. These results suggest that iNOS-derived NO affects the meiotic resumption of oocytes and signals/functions within the oocytes. Others also showed that AG markedly inhibited porcine oocyte meiotic resumption (Tao et al. 2004). Inhibitors of NOS also influence oocyte maturation in the rat (Jablonka-Shariff et al. 1999) and rabbit (Yamauchi et al. 1997). However, it has been found that nitrate/nitrite concentrations in preovulatory follicles significantly decrease after hCG injection and that iNOS plays a main role in the decrease of the intrafollicular NO concentration (Nakamura et al. 2002). Furthermore, both AG and hCG promoted oocyte GVBD in follicles cultured in vitro, and AG decreased intrafollicular cGMP levels (Nakamura et al. 2002). These results are different from our data. Nakamura et al.(2002) cultured the follicles, and iNOSNO may play its roles through the cells in the follicle wall, while we cultured the oocytes, and iNOSNO may play its roles through cumulus cells or oocytes. Furthermore, the intrafollicular components may also affect the function of iNOSNO. Overall, we predict that the iNOSNOcGMP axis may play independent roles in oocyte maturation and follicular development. The accumulation of iNOS was observed in the midbody between the separating chromosomes/chromatids at telophase I and telophase II, suggesting that iNOS-derived NO may be involved in the polar body emission. Others also found that a NOS inhibitor (L-NAME) blocked the PB1 extrusion in porcine oocytes (Tao et al. 2004). Both NOS inhibitors (L-NAME and L-NNA) suppressed the PB1 emission in mouse CEOs in a dose-dependent manner (Bu et al. 2003). Moreover, previous studies showed that fewer oocytes from eNOS knock-out mice entered the meta-phase of the second meiosis, and a greater percentage remained in metaphase I or were atypical relative to those in wild-type mice (Jablonka-Shariff & Olson 1998). Our results show that the process of PB1 emission is arrested at the anaphasetelophase transition by AG, so we predict that iNOS-derived NO is involved in the polar body emission by regulating the anaphasetelophase transition. In conclusion, our data demonstrate that iNOS-derived NO plays crucial roles within oocytes during meiotic maturation, especially in GVBD and PB1 emission.
 |
Acknowledgements
|
|---|
This work was supported by National Natural Science Foundation of China (No. 30225010, 30430530, 30170358) and Special Funds for Major State Basic Research Project (973) of China (No. G1999055902). The authors declare that there is no conflict of interest that would affect the impartiality of this scientific work.
 |
Footnotes
|
|---|
Received 21 October 2004
First decision 16 December 2004
Accepted 16 December 2004
 |
References
|
|---|
Blashkiv TV, Korniichuk AN, Voznesenskaya TY & Pornichenko AG 2001 Role of nitric oxide in ovulation, meiotic maturation of oocytes, and implantation in mice. Bulletin of Experimental Biology and Medicine 132 10341036.[Web of Science][Medline]
Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E et al. 1996 Inhibition of nitric oxide: effects of interleukin-1ß-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biology of Reproduction 54 436445.[Abstract]
Bu S, Xia G, Tao Y, Lei L & Zhou B 2003 Dual effects of nitric oxide on meiotic maturation of mouse cumulus cell-enclosed oocytes in vitro. Molecular and Cellular Endocrinology 207 2130.[CrossRef][Web of Science][Medline]
Hattori MA, Takesue K, Kato Y & Fujihara N 2001 Expression of endothelial nitric oxide synthase in the porcine oocyte and its possible function. Molecular and Cellular Biochemistry 219 121126.[CrossRef][Web of Science][Medline]
Hesla JS, Preutthipan S, Maguire MP, Chang TS, Wallach EE & Dharmarajan AM 1997 Nitric oxide modulates human chorionic gonadotropin-induced ovulation in the rabbit. Fertility and Sterility 67 548552.[CrossRef][Web of Science][Medline]
Jablonka-Shariff A & Olson LM 1997 Hormonal regulation of nitric oxide synthases and their cell-specific expression during follicular development in the rat ovary. Endocrinology 138 460468.[Abstract/Free Full Text]
Jablonka-Shariff A & Olson LM 1998 The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 139 29442954.[Abstract/Free Full Text]
Jablonka-Shariff A & Olson LM 2000 Nitric oxide is essential for optimal meiotic maturation of murine cumulus-oocyte complexes in vitro. Molecular Reproduction and Development 55 412421.[CrossRef][Web of Science][Medline]
Jablonka-Shariff A, Basuray R & Olson LM 1999 Inhibitors of nitric oxide synthase influence oocyte maturation in rats. Journal of the Society for Gynecologic Investigation 6 95101.[CrossRef][Web of Science][Medline]
Josefsberg LB, Kaufman O, Galiani D, Kovo M & Dekel N 2001 Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation. Biology of Reproduction 64 871878.[Abstract/Free Full Text]
Matsumi H, Yano T, Koji T, Ogura T, Tsutsumi O, Taketani Y et al. 1998 Expression and localization of inducible nitric oxide synthase in the rat ovary: a possible involvement of nitric oxide in the follicular development. Biochemical and Biophysical Research Communications 243 6772.[CrossRef][Web of Science][Medline]
Mitchell LM, Kennedy CR & Hartshorne GM 2004 Expression of nitric oxide synthase and effect of substrate manipulation of the nitric oxide pathway in mouse ovarian follicles. Human Reproduction 19 3040.[Abstract/Free Full Text]
Nakamura Y, Kashida S, Nakata M, Takiguchi S, Yamagata Y, Takayama H et al. 1999 Changes in nitric oxide synthase activity in the ovary of gonadotropin treated rats: the role of nitric oxide during ovulation. Endocrine Journal 46 529538.[Web of Science][Medline]
Nakamura Y, Yamagata Y, Sugino N, Takayama H & Kato H 2002 Nitric oxide inhibits oocyte meiotic maturation. Biology of Reproduction 67 15881592.[Abstract/Free Full Text]
Nemade RV, Carrette O, Larsen WJ & Markoff E 2002 Involvement of nitric oxide and the ovarian blood follicle barrier in murine follicular cyst development. Fertility and Sterility 78 13011308.[CrossRef][Web of Science][Medline]
Nishikimi A, Matsukawa T, Hoshino K, Ikeda S, Kira Y, Sato EF et al. 2001 Localization of nitric oxide synthase activity in unfertilized oocytes and fertilized embryos during preimplantation development in mice. Reproduction 122 957963.[Abstract]
Powers RW, Chen L, Russell PT & Larsen WJ 1995 Gonadotropin-stimulated regulation of bloodfollicle barrier is mediated by nitric oxide. American Journal of Physiology 269 E290E298.
Sengoku K, Takuma N, Horikawa M, Tsuchiya K, Komori H & Sharifa D et al. 2001 Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro. Molecular Reproduction and Development 58 262268.[CrossRef][Web of Science][Medline]
Shukovski L & Tsafriri A 1994 The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 135 22872290.[Abstract]
Takesue K, Tabata S, Sato F & Hattori MA 2003 Expression of nitric oxide synthase-3 in porcine oocytes obtained at different follicular development. Journal of Reproduction and Development 49 135140.
Tao Y, Fu Z, Zhang M, Xia G, Yang J & Xie H 2004 Immunohistochemical localization of inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on antrum formation and oocyte meiotic maturation. Molecular and Cellular Endocrinology 222 93103.[CrossRef][Web of Science][Medline]
Tong C, Fan HY, Lian L, Li SW, Chen DY, Schatten H et al. 2002 Polo-like kinase-1 is a pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis. Biology of Reproduction 67 546554.[Abstract/Free Full Text]
Van Voorhis BJ, Moore K, Strijbos PJLM, Nelson S, Baylis SA, Grzybicki D et al. 1995 Expression and localization of inducible and endothelial nitric oxide synthase in the rat ovary. Journal of Clinical Investigation 96 27192726.
Voznesenska TIu & Blashkiv TV 2003 Effect of NO on meiotic maturation of the oocytes in mice in vitro. Fiziolohichyi Zhurnal 49 100103.
Yamauchi J, Miyazaki T, Iwasaki S, Kishi I, Kuroshima M, ßTei C et al. 1997 Effects of nitric oxide on ovulation and ovarian steroidogenesis and prostaglandin production in the rabbit. Endocrinology 138 36303637.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
V Tripathi and A Krishna
Changes in nitric oxide (NO) synthase isoforms and NO in the ovary of Heteropneustes fossilis (Bloch.) during the reproductive cycle
J. Endocrinol.,
November 1, 2008;
199(2):
307 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|